However, most non–GC type DLBCL cases (77%) lacked blimp1 protein expression, despite the presence of blimp1 mRNA, suggesting that the same gene was inactivated by epigenetic mechanisms in an additional large number of cases. The gene discussed is PRDM1; the disease is diffuse large B-cell lymphoma.